Okusaga OO - Search Results

1

Accelerated aging in schizophrenia patients: the potential role of oxidative stress.

Okusaga OO. Okusaga OO. Aging Dis. 2013 Dec 4;5(4):256-62. doi: 10.14336/AD.2014.0500256. eCollection 2014 Aug. Aging Dis. 2013. PMID: 25110609 Free PMC article. Review.

2

The interplay between BDNF and oxidative stress in chronic schizophrenia.

Zhang XY, Chen DC, Tan YL, Tan SP, Wang ZR, Yang FD, Okusaga OO, Zunta-Soares GB, Soares JC. Zhang XY, et al. Among authors: okusaga oo. Psychoneuroendocrinology. 2015 Jan;51:201-8. doi: 10.1016/j.psyneuen.2014.09.029. Epub 2014 Oct 7. Psychoneuroendocrinology. 2015. PMID: 25462893

3

6R-l-erythro-5,6,7,8-tetrahydrobiopterin (BH4): a potential treatment for all symptom domains of schizophrenia.

Okusaga OO. Okusaga OO. Med Hypotheses. 2014 Mar;82(3):395-7. doi: 10.1016/j.mehy.2014.01.011. Epub 2014 Jan 20. Med Hypotheses. 2014. PMID: 24491428

4

Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.

Xiu MH, Yang GG, Tan YL, Chen DC, Tan SP, Wang ZR, Yang FD, Okusaga O, Soares JC, Zhang XY. Xiu MH, et al. Schizophr Res. 2014 Jun;156(1):9-14. doi: 10.1016/j.schres.2014.03.024. Epub 2014 Apr 22. Schizophr Res. 2014. PMID: 24766914

5

Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study.

Okusaga O, Hamilton RG, Can A, Igbide A, Giegling I, Hartmann AM, Konte B, Friedl M, Reeves GM, Rujescu D, Postolache TT. Okusaga O, et al. AIMS Public Health. 2014 Mar 24;1(2):43-50. doi: 10.3934/publichealth.2014.2.43. AIMS Public Health. 2014. PMID: 25346942 Free PMC article.

6

Hospital length of stay in individuals with schizophrenia with and without cocaine-positive urine drug screens at hospital admission.

Wu HE, Mohite S, Ngana I, Burns W, Shah N, Schneider L, Schmitz JM, Lane SD, Okusaga OO. Wu HE, et al. Among authors: okusaga oo. J Nerv Ment Dis. 2015 Jan;203(1):33-6. doi: 10.1097/NMD.0000000000000231. J Nerv Ment Dis. 2015. PMID: 25489749

7

Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.

Mathai AJ, Kanwar J, Okusaga O, Fuchs D, Lowry CA, Peng X, Giegling I, Hartmann AM, Konte B, Friedl M, Gragnoli C, Reeves GM, Groer MW, Rosenthal RN, Rujescu D, Postolache TT. Mathai AJ, et al. Front Public Health. 2016 Aug 30;4:182. doi: 10.3389/fpubh.2016.00182. eCollection 2016. Front Public Health. 2016. PMID: 27626030 Free PMC article.

8

Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.

Mohite S, Yang F, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Sharma AN, Fries GR, Walss-Bass C, Soares JC, Okusaga OO. Mohite S, et al. Among authors: okusaga oo. PLoS One. 2017 Mar 23;12(3):e0174073. doi: 10.1371/journal.pone.0174073. eCollection 2017. PLoS One. 2017. PMID: 28334045 Free PMC article.

9

C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia.

Boozalis T, Teixeira AL, Cho RY, Okusaga O. Boozalis T, et al. Front Public Health. 2018 Jan 22;5:360. doi: 10.3389/fpubh.2017.00360. eCollection 2017. Front Public Health. 2018. PMID: 29404313 Free PMC article.

10

Plasma Soluble P-selectin, Interleukin-6 and S100B Protein in Patients with Schizophrenia: a Pilot Study.

Pinjari OF, Dasgupta SK, Okusaga OO. Pinjari OF, et al. Among authors: okusaga oo. Psychiatr Q. 2022 Mar;93(1):335-345. doi: 10.1007/s11126-021-09954-3. Epub 2021 Oct 2. Psychiatr Q. 2022. PMID: 34599734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page